Jennifer Bell, Vanessa Zaiatz Bittencourt. Dealing with animal death and writing about it: Cultivating resilience in biotechnology writing. Medical Writing. 2025;34(1):70-73. https://journal.emwa.org/rare-diseases/biotechnology/.
Zaher Nahle. Making NAMs a ‘Complement’ to animal experimentation is the Trojan Horse of the animal-industrial complex — A scheme to nullify the principles of the 3Rs and void the quest to ‘replace’ animals for good! NAM Journal. 2025;1:100030. doi:10.1016/j.namjnl.2025.100030
Yadvinder Bhuller, Marc Avey, Raywat Deonandan, et al. Ethical principles for regulatory risk decision-making. Regulatory Toxicology and Pharmacology. 2025:105813. doi:10.1016/j.yrtph.2025.105813
Angela Bearth, Birgit Kopainsky, Lowenna B. Jones, et al. Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologies. Archives of Toxicology. 2025;99(12):4909-4930. doi:10.1007/s00204-025-04168-z
Ronin-Mae Komarnisky, Shaun Wootten, Nathan Friedman, Mehdi Nikkhah. Organ-on-a-chip: key industry insights, challenges, and opportunities from 100+ NSF I-Corps interviews. Lab on a Chip. 2025;25(19):4828-4843. doi:10.1039/d5lc00426h
Lowenna B. Jones, Paul Whaley, Angela Bearth, et al. Improving how we use workshops when solving complex research problems: reflections from the CHANGE project. Archives of Toxicology. 2025;99(8):3453-3461. doi:10.1007/s00204-025-04062-8
Editorial. Animal research is not always king: researchers should explore the alternatives. Nature. 2024;631(8021):481-481. doi:10.1038/d41586-024-02314-8